11/20/2024 5:15 AM | Guangzhou Sino-Israel Bio-Industry Investment Fund LLP (Filed by) Silexion Therapeutics (Subject)
| Form SC 13D | |
11/14/2024 8:03 AM | Silexion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 7:30 AM | Silexion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024 3:05 PM | Silexion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/31/2024 4:24 PM | Silexion Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
10/22/2024 8:02 AM | Silexion Therapeutics (Filer)
| Form DEF 14A | |
10/16/2024 11:15 PM | Silexion Therapeutics (Filer)
| Form EFFECT | |
|
10/16/2024 8:32 AM | Silexion Therapeutics (Filer)
| Form 424B3 | |
10/10/2024 4:00 PM | Silexion Therapeutics (Filer)
| Form PRE 14A | |
10/09/2024 5:04 AM | Silexion Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
10/01/2024 5:53 AM | Silexion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/24/2024 6:10 AM | Silexion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2024 3:05 PM | Silexion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/19/2024 3:06 PM | Silexion Therapeutics (Filer)
| Form 424B3 | |
09/18/2024 3:32 PM | Silexion Therapeutics (Filer)
| Form 424B3 | |
09/17/2024 11:15 PM | Silexion Therapeutics (Filer)
| Form EFFECT | |
09/09/2024 6:33 PM | Silexion Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
09/09/2024 7:00 AM | Silexion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/29/2024 3:48 PM | Silexion Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/22/2024 5:44 PM | Silexion Therapeutics (Subject) Wildcat Capital Management, LLC (Filed by)
| Form SC 13D | |
08/22/2024 4:23 PM | Moringa Sponsor, LP (Filed by) Silexion Therapeutics (Subject)
| Form SC 13D | |
08/21/2024 3:45 PM | Silexion Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/15/2024 6:38 PM | Silexion Therapeutics (Issuer) Lushi Avner (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 6:43 PM | Abramov Dror Yosef (Reporting) Silexion Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 6:47 PM | Silexion Therapeutics (Issuer) Shiloah Ilan (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 6:48 PM | Silexion Therapeutics (Issuer) Hadar Ilan (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 6:48 PM | Silexion Therapeutics (Issuer) Horenshtein Hadar Mirit (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 6:49 PM | Silexion Therapeutics (Issuer) Shirvan Mitchell (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 6:49 PM | Alon Ruth (Reporting) Silexion Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 6:50 PM | Silexion Therapeutics (Issuer) Noy Shlomo (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 6:54 PM | Silexion Therapeutics (Issuer) Levin Ilan (Reporting) Moringa Sponsor, LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 7:12 PM | Silexion Therapeutics (Issuer) Potter Leonard (Reporting) Wildcat Capital Management, LLC (Reporting) Wildcat Partner Holdings, LP (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
08/15/2024 2:22 PM | Silexion Therapeutics (Filer)
| Form CERT | |
08/15/2024 1:45 PM | Silexion Therapeutics (Filer)
| Form 8-A12B | |
07/25/2024 3:05 PM | Silexion Therapeutics (Filed by) Moringa Acquisition Corp (Subject) Moringa Acquisition Corp (Subject) Moringa Acquisition Corp (Subject) Moringa Acquisition Corp (Subject)
| Form 425 | |
07/25/2024 3:05 PM | Silexion Therapeutics (Subject) Moringa Acquisition Corp (Filed by) Moringa Acquisition Corp (Filed by) Moringa Acquisition Corp (Filed by) Moringa Acquisition Corp (Filed by)
| Form 425 | |
07/17/2024 8:06 AM | Silexion Therapeutics (Filer)
| Form 424B3 | |
07/16/2024 11:15 PM | Silexion Therapeutics (Filer)
| Form EFFECT | |
07/12/2024 3:21 PM | Silexion Therapeutics (Filer)
| Form S-4/A | |
07/05/2024 2:49 PM | Silexion Therapeutics (Filer)
| Form S-4/A | |
06/24/2024 3:49 PM | Silexion Therapeutics (Filer)
| Form S-4/A | |
Trump won. Buy this coin now. (Ad) Juan Villaverde called the top and bottom of every crypto bull market since 2012.
He believes Bitcoin will go to $150,000 — or more.
But there’s one coin he thinks could go even higher. This could be his favorite coin. |
05/09/2024 4:18 PM | Silexion Therapeutics (Filer)
| Form S-4 Registration statement under Securities Act of 1933 | |